# Insulin Glargine "All to Target" Trial

> **NCT00384085** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 588 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glulisine
- **DRUG:** Insulin Glargine
- **DRUG:** Premixed Insulin
- **DRUG:** Insulin Glulisine

## Key facts

- **NCT ID:** NCT00384085
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 588 (ACTUAL)
- **Last updated:** 2011-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384085, "Insulin Glargine "All to Target" Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00384085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*